FSHD

4 drugs in development·4 companies·4 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
losmapimod	Fulcrum Therapeutics, Inc. (FULC)
srp-1001	Sarepta Therapeutics, Inc. (SRPT)

Preclinical(1)

Drug	Company
FSHD program candidate	Dyne Therapeutics, Inc. (DYN)

Phase 1/Phase 2(1)

Drug	Company
aoc 1020	Avidity Biosciences, Inc. (RNAM)

BioSniper tracks 4 drugs in development for FSHD across 4 companies.

There are 4 clinical trials targeting FSHD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.